Geminii to Present New Lung Cancer Data on Its Bioelectronic Therapy at AACR 2026

CHICAGO, Apr. 16, 2026 /PRNewswire/ -- Geminii, Inc., a company developing bioelectronic medicines, today announced that it will present new data at the AACR Annual Meeting 2026 in San Diego highlighting its non-small cell lung cancer (NSCLC) program. The poster, titled...